Regeneron teams up with Swiss drugmaker to boost production of Covid-19 treatment

Regeneron Pharmaceuticals would nearly quadruple production capacity of its Covid-19 antibody cocktail under a new agreement with Swiss drug maker Roche. "This major collaboration with Roche provides important scale and global expertise to bring REGN-COV2 to many more patients," said Regeneron president and chief executive Len Schleifer. Under the terms of the agreement, Regeneron would focus on manufacturing and sales of the cocktail in the Unite d States and Roche would be responsible for distribution…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news